<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01806935</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A01547-36</org_study_id>
    <nct_id>NCT01806935</nct_id>
  </id_info>
  <brief_title>Xerotic Dermatitis in Aged People</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pierre Fabre Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pierre Fabre Medicament</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the the effect of the study product on itching symptoms
      associated with xerotic dermatitis in aged population
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Itching symptoms intensity change</measure>
    <time_frame>From Day 1 to 28 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">442</enrollment>
  <condition>Itching Symptoms</condition>
  <condition>Xerotic Dermatitis</condition>
  <arm_group>
    <arm_group_label>DC086</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cream</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DC086</intervention_name>
    <arm_group_label>DC086</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged from 70 years

          -  With xerotic dermatitis, clinically assessed ,

          -  At least on the anterior part of lower and/or upper limbs,

          -  Presenting itching xerotic dermatitis evolving from at least 3 weeks

          -  Intensity of itching ≥ 4 on VAS (0-10) at th inclusion time

          -  With MMSE score ≥ 20 dating less than 6 months

          -  Affiliated to a social security system, or is a beneficiary (as applicable in the
             national regulation)

        Exclusion Criteria:

          -  Criteria related to pathologies

               -  Severe form of other dermatitis requiring either systemic treatment

                  -- Itching xerotic dermatitis from iatrogenic origins

               -  Dermatological disease other than xerotic dermatitis which could interfere with
                  the assessment,

               -  Systemic disease that may generate xerotic dermatitis and /or pruritus

               -  Immunosuppression condition,

               -  History of serious disease considered by the investigator hazardous for the
                  patient or incompatible with the study.

          -  Criteria related to treatment

             - Use of treatment which could interfere with the evaluation of the disease or the
             course of the disease

          -  Criteria related to the population

               -  Ongoing participation to another clinical trial or participation in the previous
                  month before the inclusion

               -  Patient under guardianship or trusteeship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves Rolland</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Purpan CHU TOULOUSE, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>0521</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0523</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0520</name>
      <address>
        <city>Cugnaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0517</name>
      <address>
        <city>Le Fousseret</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0518</name>
      <address>
        <city>Muret</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0519</name>
      <address>
        <city>Muret</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0515</name>
      <address>
        <city>Saint Orens de Gameville</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0516</name>
      <address>
        <city>Saint Orens de Gameville</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0511</name>
      <address>
        <city>Seysses</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0512</name>
      <address>
        <city>Seysses</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0513</name>
      <address>
        <city>Seysses</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0514</name>
      <address>
        <city>Seysses</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0522</name>
      <address>
        <city>Tierce</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>0501</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2013</study_first_submitted>
  <study_first_submitted_qc>March 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2013</study_first_posted>
  <last_update_submitted>September 25, 2013</last_update_submitted>
  <last_update_submitted_qc>September 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>associated</keyword>
  <keyword>aged population</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

